Tuesday, January 22, 2013

Serial evaluation of neutrophil function in tumour-bearing dogs undergoing chemotherapy


Serial evaluation of neutrophil function in tumour-bearing dogs undergoing chemotherapy

  1. A. K. LeBlanc1,*
  2. C. J. LeBlanc2
  3. B. W. Rohrbach2
  4. S. A. Kania2
Article first published online: 20 JAN 2013
DOI: 10.1111/vco.12015


Keywords:

  • cancer;
  • canine;
  • chemotherapy;
  • flow cytometry;
  • oxidative burst;
  • phagocytosis

Abstract

We hypothesized that neutrophil function in tumour-bearing dogs is negatively impacted by chemotherapy. Flow cytometric techniques were used to assess neutrophil oxidative burst and phagocytic activities at baseline, 7 and 21 days after induction chemotherapy in 20 dogs with lymphoma. Dogs had a lower percentage of neutrophils exhibiting oxidative burst activity after stimulation with Escherichia coli(day 7; P = 0.009) and phorbol 12-myristate 13-acetate (PMA) (days 7 and 21; P = 0.0003 and P = 0.01, respectively), compared with healthy controls. From day 0 to 7, the percentage of neutrophils exhibiting oxidative burst activity decreased after stimulation with E. coli (P = 0.016) and PMA (P = 0.0006). Induction chemotherapy suppresses the percentage of neutrophils capable of oxidative burst in dogs with lymphoma, with improvement in phagocytic activity over time (P = 0.03). The impact of neutrophil dysfunction on incidence and severity of sepsis in dogs receiving chemotherapy should be investigated.